Related references
Note: Only part of the references are listed.Evaluating Second-Line Treatment Options for Type 2 Diabetes: Focus on Secondary Effects of GLP-1 Agonists and DPP-4 Inhibitors
Cassie L. Boland et al.
ANNALS OF PHARMACOTHERAPY (2013)
Economic Costs of Diabetes in the U.S. in 2012
DIABETES CARE (2013)
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Glucagonlike Peptide 1-Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus A Population-Based Matched Case-Control Study
Sonal Singh et al.
JAMA INTERNAL MEDICINE (2013)
Physicians' Prescribing Patterns for Patients with Diabetes Are Changing for the Better
Helena W. Rodbard et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
Vanita R. Aroda et al.
CLINICAL THERAPEUTICS (2012)
Can a New Ultra-Long-Acting Insulin Analogue Improve Patient Care? Investigating the Potential Role of Insulin Degludec
Jennifer D. Robinson et al.
DRUGS (2012)
Diabetes Management in the Age of National Health Reform
Robert E. Ratner
DIABETES CARE (2011)
DPP-4 Inhibitors Impact on glycemic control and cardiovascular risk factors
Dror Dicker
DIABETES CARE (2011)
The Safety of Incretin-Based Therapies-Review of the Scientific Evidence
Daniel J. Drucker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Changes in Glitazone Use Among Office-Based Physicians in the US, 2003-2009
Andrew Cohen et al.
DIABETES CARE (2010)
Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes
Anushua Sinha et al.
DIABETES CARE (2010)
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
Richard M. Bergenstal et al.
LANCET (2010)
Responding to an FDA Warning - Geographic Variation in the Use of Rosiglitazone.
Nilay D. Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Perioperative fluid management: Progress despite lingering controversies
M. A. HAMILTON
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
D. Russell-Jones et al.
DIABETOLOGIA (2009)
STATEMENT BY AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS PANEL ON TYPE 2 DIABETES MELLITUS: AN ALGORITHM FOR GLYCEMIC CONTROL
Helena W. Rodbard et al.
ENDOCRINE PRACTICE (2009)
Incretin-based therapies for type 2 diabetes mellitus
Julie A. Lovshin et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Health, Medical Care, and Economic Crisis
Ralph Catalano
NEW ENGLAND JOURNAL OF MEDICINE (2009)
National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007
G. Caleb Alexander et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
David C. Klonoff et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia A nested case-control analysis
Michael Bodmer et al.
DIABETES CARE (2008)
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes - A meta-analysis
Matteo Monami et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis
Renee E. Amori et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Six strategies to identify and assist patients burdened by out of pocket prescription costs
GC Alexander et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2004)
GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes
B Ahrén et al.
HORMONE AND METABOLIC RESEARCH (2004)
Trends in complexity of diabetes care in the United States from 1991 to 2000
RW Grant et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Share Paper
